Lysine-specific Demethylase 1 (lsd1) Is a Biomarker for Breast Cancer
The present invention relates to novel biomarker for breast cancer, namely LSD1 and its application in inter alia the diagnosis of breast cancer. Furthermore, the present invention discloses a method of determining the LSD1 protein amount and the effect of LSD1 inhibitors on cancer cells selected from breast cancer, lung carcinoma and sarcoma.
SCHUELE ROLAND [DE]; METZGER ERIC [FR]; BUETTNER REINHARD [DE]; KIRFEL JUTTA [DE]
Type of Offer:
« More Healthcare Patents